| 1 |
33768560 | Association between interleukin 28B polymorphism and sustained virological response to sofosbuvir plus daclatasvir in chronic hepatitis C genotype 4 Egyptian patients. | 2021 Aug |
3 |
| 2 |
31914336 | Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C. | 2020 Feb |
1 |
| 3 |
30431653 | Polymorphism in interferon λ3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy. | 2019 Apr |
6 |
| 4 |
28884930 | Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy. | 2018 Mar |
1 |
| 5 |
28892235 | Beclabuvir in combination with asunaprevir and daclatasvir for hepatitis C virus genotype 1 infection: A systematic review and meta-analysis. | 2018 May |
1 |
| 6 |
27022224 | Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1. | 2016 Mar 28 |
1 |
| 7 |
24612030 | Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection. | 2014 Dec |
1 |
| 8 |
25059552 | Efficacy of daclatasvir in hepatitis C virus. | 2014 Sep |
1 |